STRATEC Biomedical AG 

08.07.2015 17:44

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Correction of the release from 8 July 2015
Ameriprise International Holdings GmbH, Zug, Switzerland, has notified us on 3 July 2015 pursuant to § 21 sec. 1 WpHG that on 29 June 2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, exceeded the threshold of 3% and amounted on that day to 4.87% (575,168 voting rights). The voting rights are attributable pusuant to § 22 para. 1 sent. 1 No. 6 in connection with sent. 2 WpHG. Shareholder, which voting rights are attributed and equal or exceed 3%: Threadneedle Investment Funds ICVC.



08.07.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---